We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$121B
AUM Growth
+$6.29B
Cap. Flow
+$257M
Cap. Flow %
0.21%
Top 10 Hldgs %
24.67%
Holding
4,045
New
183
Increased
1,650
Reduced
1,805
Closed
213

Sector Composition

Rank Sector Weight
1 Technology 15.49%
2 Financials 8.61%
3 Healthcare 8.48%
4 Industrials 6.86%
5 Consumer Discretionary 5.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JCI icon
101
Johnson Controls International
JCI
$92.2B
$220M 0.18%
3,232,338
+2,592,448
+405% +$159M
PXD
102
DELISTED
Pioneer Natural Resource Co.
PXD
$220M 0.18%
1,061,412
+42,653
+4% +$8.98M
ICE icon
103
Intercontinental Exchange
ICE
$84.4B
$218M 0.18%
1,927,616
+34,539
+2% +$3.74M
XLU icon
104
State Street Utilities Select Sector SPDR ETF
XLU
$22.7B
$218M 0.18%
6,653,598
+777,190
+13% +$26.2M
FTCS icon
105
First Trust Capital Strength ETF
FTCS
$7.95B
$217M 0.18%
2,895,936
-192,093
-6% -$14.1M
NVO
106
Novo Nordisk
NVO
$209B
$217M 0.18%
2,685,972
-219,882
-8% -$18M
TGT icon
107
Target
TGT
$68B
$217M 0.18%
1,646,714
-223,321
-12% -$33.1M
TLT icon
108
iShares 20+ Year Treasury Bond ETF
TLT
$40.9B
$214M 0.18%
2,083,380
+313,910
+18% +$32.6M
T icon
109
AT&T
T
$163B
$211M 0.17%
13,230,800
+1,054,627
+9% +$18M
DE icon
110
Deere & Co
DE
$168B
$209M 0.17%
514,748
-20,718
-4% -$7.92M
CVS icon
111
CVS Health
CVS
$122B
$207M 0.17%
2,994,891
-4,257
-0.1% -$303K
BBY icon
112
Best Buy
BBY
$17.3B
$205M 0.17%
2,499,501
+145,916
+6% +$10.9M
DIS icon
113
Walt Disney
DIS
$181B
$199M 0.16%
2,233,094
-40,994
-2% -$3.88M
BMY icon
114
Bristol-Myers Squibb
BMY
$132B
$195M 0.16%
3,047,925
+225,434
+8% +$15.1M
TT icon
115
Trane Technologies
TT
$106B
$189M 0.16%
988,622
+10,366
+1% +$1.84M
BDX icon
116
Becton Dickinson
BDX
$48.2B
$188M 0.16%
712,849
-4,183
-0.6% -$1.06M
AZN icon
117
AstraZeneca
AZN
$250B
$188M 0.15%
1,314,163
+25,628
+2% +$3.77M
BLK icon
118
Blackrock
BLK
$176B
$188M 0.15%
271,952
+18,789
+7% +$12.6M
NXPI icon
119
NXP Semiconductors
NXPI
$60.4B
$185M 0.15%
905,604
+33,942
+4% +$6.03M
SHY icon
120
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$182M 0.15%
2,243,178
-343,628
-13% -$28.1M
LOW icon
121
Lowe's Companies
LOW
$125B
$182M 0.15%
804,647
-10,906
-1% -$2.27M
IQV icon
122
IQVIA
IQV
$39.3B
$179M 0.15%
797,067
+27,549
+4% +$5.53M
LHX icon
123
L3Harris
LHX
$53.4B
$178M 0.15%
909,036
+31,170
+4% +$5.96M
NKE icon
124
Nike
NKE
$61.9B
$178M 0.15%
1,610,214
-60,609
-4% -$7.09M
IBM icon
125
IBM
IBM
$224B
$177M 0.15%
1,322,676
-8,323
-0.6% -$1.07M

Similar funds

Raymond James & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Raymond James & Associates held 4,045 positions worth $121B, up 5.5% from $115B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q2 2023 filing shows 183 new, 1,650 increased, 1,805 reduced and 213 closed positions. Its largest new stake was Choice Hotels: 212,259 shares worth $24.9M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $562M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2023 buy was Choice Hotels: 212,259 shares worth $24.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2023, an estimated $753M increase.
  • Raymond James & Associates's biggest Q2 2023 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $562M.
  • Raymond James & Associates fully exited ABB Ltd in Q2 2023, selling an estimated $17.1M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $121B portfolio in Q2 2023.
  • Raymond James & Associates opened 183 new positions and closed 213 in Q2 2023.
  • Raymond James & Associates's portfolio value rose 5.5% quarter-over-quarter to $121B.

Based on Raymond James & Associates's 13F filing for Q2 2023, filed 25 Jul 2023.